Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

Market Cap	750.06M
Revenue (ttm)	406.12M
Net Income (ttm)	6.07M
Shares Out	n/a
EPS (ttm)	0.38
PE Ratio	123.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,902
Average Volume	19,047
Open	45.77
Previous Close	45.40
Day's Range	45.45 - 46.38
52-Week Range	40.40 - 91.87
Beta	1.54
RSI	51.86
Earnings Date	May 30, 2025

About NSE:BIOFILCHEM

Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications. It also provides job work service for manufacturing pharmaceutical drugs. Biofil ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 26
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BIOFILCHEM

Financial Performance

In 2023, NSE:BIOFILCHEM's revenue was 404.09 million, an increase of 34.54% compared to the previous year's 300.35 million. Earnings were 7.09 million, an increase of 26.55%.